Jordi Riba
Pioneer Researcher in Ayahuasca Pharmacology (1968-2020)
Key Impact
Conducted the first placebo-controlled trials with ayahuasca, establishing its safety and neurophysiological impact.
Background & Research
Jordi Riba was a visionary pharmacologist who led the first scientific investigations into ayahuasca in human volunteers. His seminal work at the Universitat Autònoma de Barcelona and Maastricht University demonstrated the safety and pharmacokinetics of orally active DMT and utilized neuroimaging to map the brain's response to the 'Amazonian brew.' His research laid the foundation for modern clinical science on ayahuasca.
Collaboration Network
44 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Depressive DisordersNeuroimaging & Brain MeasuresHealthy VolunteersSubstance Use Disorders (SUD)Anxiety DisordersTreatment-Resistant Depression (TRD)CreativityMajor Depressive Disorder (MDD)Personality & Trait FactorsPublic Health, Prevention & Behaviour ChangeImmunology & InflammationInterpersonal Functioning & Social ConnectednessBipolar DisorderSafety & Risk ManagementBorderline Personality Disorder (BPD)Personality DisordersMedicinal Chemistry & Drug DevelopmentNeurocognitive DisordersSet & SettingAlcohol Use Disorder (AUD)PTSDSchizophreniaNeurological InjuryChronic Pain